Vimarsana
Biggest News Aggregation in the World

Michael Lichtenberg News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michael Lichtenberg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michael Lichtenberg Today - Breaking & Trending Today

Innovative Aspiration Thrombectomy System by Expanse ICE Receives FDA Clearance for vessels of the peripheral arterial and venous systems - Vimarsana News

Innovative Aspiration Thrombectomy System by Expanse ICE Receives FDA Clearance for vessels of the peripheral arterial and venous systems

PLEASANTON, Calif., April 22, 2024 /PRNewswire/ -- Expanse ICE announced today the ICE Aspiration System has received 510(k) clearance from the U.S. Food and

Will IVUS Ever Take Off in Peripheral Vascular Interventions? - Vimarsana News

Will IVUS Ever Take Off in Peripheral Vascular Interventions?

Experts at ISET 2024 made the case for IVUS, but given how slow uptake has been in the coronary space, the mood was a bit skeptical.

Source: tctmd.com
Avinger, Inc. (NASDAQ:AVGR) Q2 2023 Earnings Call Transcript - Vimarsana News

Avinger, Inc. (NASDAQ:AVGR) Q2 2023 Earnings Call Transcript

Operator: Greetings and welcome to the Avinger Second Quarter 2023 Results Call. At this time, all participants are in a listen-only mode.

Early Data on Temporary Spur in BTK PAD Show Efficacy, Limited Recoil - Vimarsana News

Early Data on Temporary Spur in BTK PAD Show Efficacy, Limited Recoil

The spiky stent may limit vessel recoil and improve drug delivery, but it’s still too early for strong conclusions, says Sahil Parikh.

Source: tctmd.com
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA22 - Vimarsana News

Second Round of Late-Breaking Clinical Trial Results Announced at VIVA22

/PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and...